SIAMAB THERAPEUTICS, INC. — Form D/A
SIAMAB THERAPEUTICS, INC. of NEWTON, MA, a company, filed a Form D amendment with the SEC on 2016-03-30. The offering totals $7.0M, of which $3.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-03-30
- Form: D/A
- Accession: 0001351615-16-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $3.2M
- Remaining: $3.8M
- Investors: 64
- Date of first sale: 2015-03-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-237587
Issuer
- Name: SIAMAB THERAPEUTICS, INC.
- CIK: 0001351615
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 90 BRIDGE STREET, SUITE 100, NEWTON, MA, 02458
- Phone: 800-513-1569
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Robert Mashal | Director | Newton, MA |
| SUNDAR SUBRAMANIAM | Director | Boston, MA |
| SUNDAR SUBRAMANIAM | Executive Officer | Boston, MA |
| Jeffrey Behrens | Director | Newton, MA |
| Jeffrey Behrens | Executive Officer | Newton, MA |
| Gary Pforzheimer | Director | Newton, MA |
| Brad Curley | Director | Newton, MA |
| Peter Kroon | Director | Newton, MA |
| Mark Hattendorf | Director | Los Angeles, CA |
| Mark Hattendorf | Executive Officer | Los Angeles, CA |
| Ajit Varki | Director | Newton, MA |
| Nissi Varki | Director | Vista, CA |
Other filings by this issuer (8)
More